TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank83
3Y CAGR-1.6%
5Y CAGR+22.5%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-1.6%/yr
Annual compound
5Y CAGR
+22.5%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.41 | +56.8% |
| 2024 | 0.26 | -22.7% |
| 2023 | 0.34 | -21.4% |
| 2022 | 0.43 | +1244.4% |
| 2021 | 0.03 | -78.5% |
| 2020 | 0.15 | +51.0% |
| 2019 | 0.10 | - |